Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence.
de Pádua Covas Lage LA, De Vita RN, de Oliveira Alves LB, Jacomassi MD, Culler HF, Reichert CO, de Freitas FA, Rocha V, Siqueira SAC, de Oliveira Costa R, Pereira J. de Pádua Covas Lage LA, et al. Among authors: culler hf. Cancers (Basel). 2024 Apr 11;16(8):1459. doi: 10.3390/cancers16081459. Cancers (Basel). 2024. PMID: 38672542 Free PMC article.
Up-Front ASCT Overcomes the Survival Benefit Provided by HDAC-Based Induction Regimens in Mantle Cell Lymphoma: Data from a Real-Life and Long-Term Cohort.
de Pádua Covas Lage LA, Elias MDV, Reichert CO, Culler HF, de Freitas FA, de Oliveira Costa R, Rocha V, da Siqueira SAC, Pereira J. de Pádua Covas Lage LA, et al. Among authors: culler hf. Cancers (Basel). 2023 Sep 28;15(19):4759. doi: 10.3390/cancers15194759. Cancers (Basel). 2023. PMID: 37835453 Free PMC article.
High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.
de Pádua Covas Lage LA, Machado PPF, Reichert CO, Miranda E, Culler HF, da Siqueira SAC, de Oliveira Costa R, Miyashiro DR, Sanches JA, Rocha V, Chiattone CS, Pereira J. de Pádua Covas Lage LA, et al. Among authors: culler hf. Sci Rep. 2022 Nov 29;12(1):20557. doi: 10.1038/s41598-022-25034-3. Sci Rep. 2022. PMID: 36446856 Free PMC article.
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.
Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas JA, Saed B, Perera T, Hu Y, Reneau J, Sverdlov M, Wolfe A, Brown N, Harms P, Bailey NG, Inamdar K, Hristov AC, Tejasvi T, Montes J, Barrionuevo C, Taxa L, Casavilca S, de Pádua Covas Lage JLA, Culler HF, Pereira J, Runge JS, Qin T, Tsoi LC, Hong HS, Zhang L, Lyssiotis CA, Ohe R, Toubai T, Zevallos-Morales A, Murga-Zamalloa C, Wilcox RA. Geng X, et al. Among authors: culler hf. Blood Cancer J. 2022 Nov 4;12(11):149. doi: 10.1038/s41408-022-00745-y. Blood Cancer J. 2022. PMID: 36329027 Free PMC article.
The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA, Araújo Soares V, Meneguin TD, Culler HF, Reichert CO, Jacomassi MD, Reis DGC, Zerbini MCN, de Oliveira Costa R, Rocha V, Pereira J. de Pádua Covas Lage LA, et al. Among authors: culler hf. Radiat Oncol. 2022 Oct 22;17(1):171. doi: 10.1186/s13014-022-02142-y. Radiat Oncol. 2022. PMID: 36273167 Free PMC article.
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA, Barreto GC, Culler HF, Cavalcante JB, de Oliveira Alves LB, Nardinelli L, Bendit I, Zerbini MCN, Rocha V, Pereira J. de Pádua Covas Lage LA, et al. Among authors: culler hf. Cancer Biomark. 2022;35(2):179-191. doi: 10.3233/CBM-220013. Cancer Biomark. 2022. PMID: 36093687
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
Lage LAPC, Brito CV, Barreto GC, Culler HF, Reichert CO, Levy D, Costa RO, Zerbini MCN, Rocha V, Pereira J. Lage LAPC, et al. Among authors: culler hf. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):812-824. doi: 10.1016/j.clml.2022.06.012. Epub 2022 Jun 29. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35869020
20 results